Tetsuhiro Yamada

476 total citations
20 papers, 281 citations indexed

About

Tetsuhiro Yamada is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Tetsuhiro Yamada has authored 20 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in Tetsuhiro Yamada's work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Nitric Oxide and Endothelin Effects (2 papers). Tetsuhiro Yamada is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Nitric Oxide and Endothelin Effects (2 papers). Tetsuhiro Yamada collaborates with scholars based in Japan, Switzerland and United Kingdom. Tetsuhiro Yamada's co-authors include Tetsuo Asaki, Kenji Kuwabara, Keiichi Kuwano, Asami Hashino, Taisuke Hamamoto, Akio Nakamura, Tim Mant, Priska Kaufmann, Shirin Bruderer and Jasper Dingemanse and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Pharmaceutical Research.

In The Last Decade

Tetsuhiro Yamada

18 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuhiro Yamada Japan 6 161 113 59 44 35 20 281
Keiichi Kuwano Japan 6 224 1.4× 160 1.4× 67 1.1× 61 1.4× 42 1.2× 9 358
M Sekiguchi Japan 11 83 0.5× 78 0.7× 69 1.2× 44 1.0× 13 0.4× 28 394
Ulrike Glaenzel Switzerland 8 40 0.2× 71 0.6× 95 1.6× 20 0.5× 16 0.5× 10 334
Elizabeth Rafeiro Canada 13 65 0.4× 45 0.4× 69 1.2× 264 6.0× 27 0.8× 20 499
Tatsuro Ogawa Japan 11 95 0.6× 45 0.4× 107 1.8× 53 1.2× 19 0.5× 20 345
Nassr Nassr Germany 11 104 0.6× 42 0.4× 169 2.9× 108 2.5× 30 0.9× 14 359
R Butt Canada 9 33 0.2× 150 1.3× 52 0.9× 31 0.7× 103 2.9× 18 320
Jue Chen China 11 33 0.2× 29 0.3× 216 3.7× 45 1.0× 25 0.7× 16 372
Megumi Yasuoka Japan 9 57 0.4× 35 0.3× 191 3.2× 33 0.8× 33 0.9× 13 354
Laura Gehrke United States 5 64 0.4× 84 0.7× 110 1.9× 149 3.4× 12 0.3× 5 334

Countries citing papers authored by Tetsuhiro Yamada

Since Specialization
Citations

This map shows the geographic impact of Tetsuhiro Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuhiro Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuhiro Yamada more than expected).

Fields of papers citing papers by Tetsuhiro Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuhiro Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuhiro Yamada. The network helps show where Tetsuhiro Yamada may publish in the future.

Co-authorship network of co-authors of Tetsuhiro Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuhiro Yamada. A scholar is included among the top collaborators of Tetsuhiro Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuhiro Yamada. Tetsuhiro Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Banshoya, Kengo, Tetsuhiro Yamada, Yoichi Kawamoto, et al.. (2024). Development of a Water-Soluble Nanomicellar Formulation Loaded with Trans-Resveratrol Using Polyethylene Glycol Monostearate for the Treatment of Intracerebral Hemorrhage. Pharmaceutics. 16(11). 1462–1462. 1 indexed citations
3.
Imai, Shunji, et al.. (2023). Prediction of Human Pharmacokinetics of Phosphorodiamidate Morpholino Oligonucleotides in Duchenne Muscular Dystrophy Patients Using Viltolarsen. Drug Metabolism and Disposition. 51(10). 1428–1435. 5 indexed citations
4.
Imai, Shunji, T Arai, Tetsuhiro Yamada, & Makoto Niwa. (2020). Improved In Vitro-In Vivo Correlation by Using the Unbound-Fraction-Adjusted IC50 for Breast Cancer Resistance Protein Inhibition. Pharmaceutical Research. 37(12). 230–230. 4 indexed citations
5.
Lewis, Matthew R., et al.. (2019). Reducing the Time Burdens of Army Company Leaders. RAND Corporation eBooks. 3 indexed citations
6.
Imai, Shunji, et al.. (2018). Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag In Vitro. Journal of Pharmaceutical Sciences. 108(2). 1027–1034. 13 indexed citations
7.
Ichikawa, Tomohiko, et al.. (2018). Cross-species comparison of the metabolism and excretion of selexipag. Xenobiotica. 49(3). 284–301. 3 indexed citations
8.
Gnerre, Carmela, Päivi Äänismaa, Thomas Pfeifer, et al.. (2017). The metabolism and drug–drug interaction potential of the selective prostacyclin receptor agonist selexipag. Xenobiotica. 48(7). 704–719. 14 indexed citations
9.
Ichikawa, Tomohiko, et al.. (2017). Pharmacokinetics of the selective prostacyclin receptor agonist selexipag in rats, dogs and monkeys. Xenobiotica. 48(2). 186–196. 5 indexed citations
10.
Kaufmann, Priska, et al.. (2015). Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag. American Journal of Cardiovascular Drugs. 15(3). 195–203. 48 indexed citations
11.
Yamada, Tetsuhiro, et al.. (2011). In vitrometabolism of dexamethasone cipecilate, a novel synthetic corticosteroid, in human liver and nasal mucosa. Xenobiotica. 41(10). 874–884. 2 indexed citations
12.
Nakamura, Akio, et al.. (2011). Effects of Etodolac on P450 Isoform-specific Activities in Human Hepatic Microsomes. Arzneimittelforschung. 55(12). 744–748. 1 indexed citations
13.
Yamada, Tetsuhiro, et al.. (2011). In vitro Melanin Binding of NS-49, a Phenethylamine Class α1A-Adrenoceptor Agonist. Arzneimittelforschung. 51(4). 299–303.
14.
Kamei, T., Tetsuhiro Yamada, Takao Koike, et al.. (2009). A 65nm dual-mode baseband and multimedia application processor SoC with advanced power and memory management. 535–539. 1 indexed citations
15.
Nakamura, Akio, Tetsuhiro Yamada, & Tetsuo Asaki. (2007). Synthesis and evaluation of N-acylsulfonamide and N-acylsulfonylurea prodrugs of a prostacyclin receptor agonist. Bioorganic & Medicinal Chemistry. 15(24). 7720–7725. 28 indexed citations
16.
Kuwano, Keiichi, Asami Hashino, Tetsuo Asaki, et al.. (2007). 2-{4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), an Orally Available and Long-Acting Prostacyclin Receptor Agonist Prodrug. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1181–1188. 141 indexed citations
17.
Matsuo, Shinro, et al.. (2005). Effect of Statin Therapy on Arterial Stiffness in Patients with Hyperlipidemia:Shiga Pravastatin Atherosclerosis Study (SHIPAS) Group. 4 indexed citations
18.
Nakamura, Yasuyuki, Shinji Tamaki, Nobuyuki Ohmichi, et al.. (2004). Angiotensin Converting Enzyme Genotype Influences the Response to the Angiotensin II Receptor Antagonist Losartan in Patients with Hypertension. Hypertension Research. 27(3). 137–140. 4 indexed citations
19.
Yamada, Tetsuhiro, et al.. (1984). [Allergic study of interstitial cystitis. (1) A case of interstitial cystitis caused by squid and shrimp hypersensitivity].. PubMed. 33(5). 264–8. 2 indexed citations
20.
Shinohara, S, et al.. (1983). Modification of the sensitivity of CHO cells to mitomycin C by dibutyryl cyclic AMP. Biochemical and Biophysical Research Communications. 111(1). 247–252. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiichi Kuwano Breakdown of academic impact, for papers by M Sekiguchi Breakdown of academic impact, for papers by Ulrike Glaenzel Breakdown of academic impact, for papers by Elizabeth Rafeiro Breakdown of academic impact, for papers by Tatsuro Ogawa Breakdown of academic impact, for papers by Nassr Nassr Breakdown of academic impact, for papers by R Butt Breakdown of academic impact, for papers by Jue Chen Breakdown of academic impact, for papers by Megumi Yasuoka Breakdown of academic impact, for papers by Laura Gehrke
Rankless by CCL
2026